John Vong - 07 Aug 2026 Form 3 Insider Report for Astrana Health, Inc. (ASTH)

Source evidence Original filing metadata and source links for verification. 4 source fields
SEC form
3
Accepted by SEC
11 Aug 2026, 17:37:09 UTC
Prior SEC filing
03 Dec 2024
Source filing
View source filing
Reporting owner 1 detail
Reporting owner signature
/s/ Kathy Diep, as Attorney-in-Fact

Key filing fact

John Vong filed Form 3 for Astrana Health, Inc. (ASTH) on 11 Aug 2026.

Key facts

  • This page summarizes John Vong's Form 3 filing for Astrana Health, Inc. (ASTH).
  • 0 reported transactions and 0 derivative rows are listed below.
  • Accepted by SEC: 11 Aug 2026, 17:37.

Change

  • Previous filing in this sequence was filed on 03 Dec 2024.
  • Current net transaction value: $0.

Research use

  • This tells you what this filing adds before you inspect full transaction and derivative tables.
  • You can trace every row back to the original SEC filing document.

Evidence

Official SEC source

Ownership activity is grounded in SEC Form 3 disclosures.

View source filing

Reporting Owners (1)

CIK 0001572846 Primary reporting owner

Vong John

Relationship
SVP - Accounting (PAO)
Address
C/O ASTRANA HEALTH, INC., 1668 S. GARFIELD AVE, 2ND FLOOR, ALHAMBRA
Signature
/s/ Kathy Diep, as Attorney-in-Fact
Signature date
11 Aug 2026

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

ASTH holding

Common Stock

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after
22,426
Date
07 Aug 2026
Ownership
Direct
Footnotes
F1, F2
* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 2 footnotes

Footnote F1

Includes 3,972 shares of restricted stock, which will vest as follows (in each case subject to continuous employment with the Issuer): (i) 380 shares which will vest on November 30, 2026; and (ii) tranches of 454 shares, 454 shares, 454 shares, 454 shares, and 1,776 shares, each of which will vest in two equal semi-annual installments beginning on November 12, 2026. Also includes the following restricted stock units, which will vest as follows (in each case subject to continuous employment with the Issuer): (i) 3,104 restricted stock units, which will vest in two equal semi-annual installments beginning on October 10, 2026; and (ii) 2,156 restricted stock units, which will vest in eight equal semi-annual installments beginning September 15, 2026.

Footnote F2

Includes 584 shares acquired under the Issuer's Employee Stock Purchase Plan.

SEC remarks

Power of Attorney is attached hereto as Exhibit 24.

We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .